| Literature DB >> 15701552 |
Anthony A Marfin1, Rachel S Barwick Eidex, Phyllis E Kozarsky, Martin S Cetron.
Abstract
Appropriate administration of yellow fever or Japanese encephalitis vaccines to travelers requires an assessment of the traveler's risk for infection with these vector-borne flaviviruses during their travels and the presence of risk factors for adverse events following immunization. Japanese encephalitis and yellow fever vaccines have been more frequently associated with serious adverse events following immunization since the early 1980s and the late 1990s, respectively. This article describes the adverse events, the magnitude of their risk, and associated risk factors.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15701552 DOI: 10.1016/j.idc.2004.11.004
Source DB: PubMed Journal: Infect Dis Clin North Am ISSN: 0891-5520 Impact factor: 5.982